Anlotinib + Benmelstobart vs Surgery for Patients With Localized Renal Cell Carcinoma Scheduled to Undergo Partial Nephrectomy
Clinical trial NCT07627464 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07627464
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-31
- Primary completion
- 2028-12-31
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.